Episodios

  • #022 - Doug Drysdale, CEO of Cybin Inc.
    Feb 25 2022
    On this episode of Psychedelic Insiders, Doug Drysdale, CEO of Cybin Inc. powers through a cold to share some insights on the present and future of psychedelic medicine. He talks to Microdose's Jason Najum about psychedelic drug development, mental health therapies involving psychedelics, and more. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: Video of interview: https://youtu.be/7AfG58q-KGw www.cybin.com www.microdose.buzz Subscribe today! on Apple Podcasts: https://podcasts.apple.com/us/podcast/psychedelic-insiders/id1531628901 on Spotify: https://open.spotify.com/show/3Nyc58Ov7GYBeeLcWheBSx on Youtube: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1
    Más Menos
    27 m
  • #021 - Jeeshan Chowdhury, Co-Founder & CEO of Journey CoLab
    Feb 1 2022
    On this episode of Psychedelic Insiders, Jeeshan Chowdhury, Co-Founder & CEO of Journey CoLab opens up about his intentional path set for the company, using mescaline as medicine to combat endemic addictions like Alcohol Use Disorder. He talks to Jason Najum about drug development, psychedelic mental health care, and more. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: Video of interview: https://youtu.be/qq2wCyJ3aCc www.journeycolab.com www.microdose.buzz Subscribe today! on Apple Podcasts: https://podcasts.apple.com/us/podcast/psychedelic-insiders/id1531628901 on Spotify: https://open.spotify.com/show/3Nyc58Ov7GYBeeLcWheBSx on Youtube: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1
    Más Menos
    30 m
  • #020 - Najla Guthrie, CEO of KGK Science
    Jan 20 2022
    On this episode of Psychedelic Insiders, Najla Guthrie, CEO of KGK Science opens up about her 25 years experience in straightening out the wild field of natural medicines. She talks to Jason Najum about her business experience, how to go about drug development the right way, various regulatory bodies, and more. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: Video of interview: https://youtu.be/XJL1FKmi4JI www.kgkscience.com www.microdose.buzz
    Más Menos
    19 m
  • #019 - Janet Qi, CEO & Founder - PurMinds Biopharma
    Dec 21 2021
    Janet talks about her mission to pursue breakthrough medicines via her company PurMinds Biopharma. She talks to Jason Najum about her business experience, ALS, data science, drug development, neuroscience, the FDA, and more. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: www.purminds.com www.microdose.buzz Subscribe to the Playlist: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1 Hashtags: #PurMinds #FemaleCEO #BioPharma #JanetQi #MentalHealth #ALS #Psychedelics #Psychedelia #Health #Medicine #Healing #Pharmaceuticals #DrugDevelopment #ClinicalTrials
    Más Menos
    23 m
  • #018 - Panjak Gogia, CEO, Psychedelic Water, A CPG Drinks Brand in Psychedelics
    Nov 29 2021
    “Everyday is psychedelic”, that’s the motto of Psychedelic Water, the world’s first legal psychedelic beverage.Microdose writer Jason Najum sat down with Psychedelic Water CEO Pankaj Gojia to discuss the company's mission and product. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: VIDEO VERSION: https://youtu.be/kQA-Oemyy-Q www.psychedelicwater.com www.microdose.buzz
    Más Menos
    16 m
  • #017 - Robin Arnott, CEO of Entheo Digital — a Company Doing Psychedelic VR
    Nov 3 2021
    Robin Arnott has been studying ways of invoking psychedelic experiences through technology. Jason Najum goes deep into the nebulous realm of possible human experiences. Watch the live video interview at: https://youtu.be/p_coZ3pZ-wQ PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. https://my.captivate.fm/www.microdose.buzz (www.microdose.buzz)
    Más Menos
    19 m
  • #016 - Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins
    Oct 26 2021
    Matthew Johnson, graced by the psychedelic Gods with regulatory approval and grants from the US Federal government, has been studying psychedelics with fervour as they are his pharmacological passion. Jason Najum of Microdose Psychedelic Insights takes us on a wild ride of an interview that may or may not end in Jason's microdose turning him into a cat. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. https://my.captivate.fm/www.microdose.buzz (www.microdose.buzz) Matthew JohnsonSusan Hill Ward Professor of Psychedelics and Consciousness Johns Hopkins University School of Medicine Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins University School of Medicine. Working with psychedelics since 2004, he is one of the world’s most widely published experts on psychedelics. He has published over 150 scientific papers, including psychedelic safety guidelines (2008) that helped to resurrect human psychedelic research, first research on psychedelic treatment of tobacco addiction (2014), and studies of psilocybin in cancer-related distress (2016) and depression (2020). His psilocybin review recommended Schedule IV upon potential medical approval (2018). Matt also conducts behavioral economic research on the psychology of addiction and sexual risk. He is a past President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association, and current President of the International Society for Research on Psychedelics. In 2021 Matt received as principal investigator the first grant awarded by the US government in 50 years for a treatment trial of a classic psychedelic (psilocybin for smoking cessation). He has been interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, the BBC, CNN, Fox Business News, NPR, and in Michael Pollan’s book How to Change Your Mind. Twitter: @Drug_Researcher
    Más Menos
    42 m
  • #015 - Bonus Episode: Sanjeev Gaol & Neeraj Jain of Peak Human on the Psychedelic Frontiers Virtual Summit
    Oct 21 2021
    In support of fellow advocates and entrepreneurs in the psychedelic medicine space, Mircrodose sat down with the team behind the "Psychedelic Frontiers Virtual Summit". The virtual conference is taking place this weekend and will feature interviews with over 40 leading experts in the field. The event is free to attend. Check it out at: https://www.psychedelicfrontiers.ca/ (www.psychedelicfrontiers.ca) PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. www.microdose.buzz
    Más Menos
    13 m